BS

Bheemisetty Sarath Chakravarthi

Active Director Director DIN 10142061
DIN 10142061 First appointment Apr 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Bheemisetty Sarath Chakravarthi

Data last updated:

Bheemisetty Sarath Chakravarthi is a Director at Dr Winz Pharmaceuticals Private Limited (since 2023). The company operates in Paper.

DIN 10142061
Primary Designation Director
Industry Paper
First Appointment 30 Apr 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Apr 20232023Active

Directorship timeline

Open interactive timeline →
Dr Winz Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Bheemisetty Sarath Chakravarthi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bheemisetty Sarath Chakravarthi

Bheemisetty Sarath Chakravarthi currently holds 1 directorship: Dr Winz Pharmaceuticals Private Limited (Director, since 30 Apr 2023).

Bheemisetty Sarath Chakravarthi was first appointed on 30 Apr 2023 as Director at Dr Winz Pharmaceuticals Private Limited.

The current boards of Bheemisetty Sarath Chakravarthi's companies include Mahanthi Salamkayala (Dr Winz Pharmaceuticals Private Limited), Adithya Maddali (Dr Winz Pharmaceuticals Private Limited), Budigi Anjaiah (Dr Winz Pharmaceuticals Private Limited), Dawood Basha Syed (Dr Winz Pharmaceuticals Private Limited), Paparao Bhimisetty (Dr Winz Pharmaceuticals Private Limited), Sandhya Rani Kolla (Dr Winz Pharmaceuticals Private Limited), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available